Lateral Flow β2TF Detection for Rapid CSF Leak Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting cerebrospinal fluid (CSF) leakage, such as electrophoresis, are time-consuming and require specialized laboratories, making them unsuitable for rapid, point-of-care diagnosis during surgical procedures.
Innovation Solution
A lateral flow device using transferrin-binding antibodies and lectin molecules conjugated to nanoparticles, combined with a serum line, allows for rapid detection of β2TF in biological samples by calculating an optical value from signal intensities at specific domains, enabling quick identification of CSF leakage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If electrophoresis is used to detect β2TF, then detection precision is improved, but detection time increases and device complexity increases
Solution Approach 1:
The patent extracts the specific detection function for β2TF from the complex electrophoresis system by using antibodies that specifically bind to β2TF. This allows the detection of β2TF to be performed independently without requiring the entire electrophoresis process, thereby reducing detection time while maintaining precision through specific antibody-antigen recognition.
Solution Approach 2:
The patent replaces the mechanical electrophoresis system with an immunological detection system using antibodies conjugated to nanoparticles. This substitution eliminates the need for complex electrophoresis equipment and lengthy separation processes, achieving rapid detection within 30 minutes while maintaining high detection precision through specific immunological recognition.
2Measurement precision
If electrophoresis is used to detect β2TF, then detection precision is improved, but device complexity increases
Solution Approach 1:
The patent extracts the essential detection function from the complex electrophoresis system by using specific antibodies conjugated to nanoparticles. This allows the detection to be performed with a simplified device that does not require electrophoresis equipment, reducing device complexity while maintaining detection precision through specific immunological recognition.
Solution Approach 2:
The patent replaces the complex mechanical electrophoresis system with a simpler immunological detection system using antibody-conjugated nanoparticles. This substitution eliminates the need for complex separation equipment and specialized laboratories, achieving the same detection precision with a much simpler device suitable for point-of-care use.
3Speed
If a lateral flow device with multiple domains is used, then detection speed is improved, but device complexity increases
Solution Approach 1:
The patent divides the detection function into multiple specialized domains within the lateral flow device: a first domain for detecting total transferrin and a second domain for detecting β2TF specifically. This segmentation allows simultaneous parallel detection of different markers, achieving rapid detection while organizing complexity into functional modules that can be manufactured and used efficiently.
Solution Approach 2:
The lateral flow device is designed with multi-functionality by incorporating multiple detection domains that can simultaneously detect different markers (total transferrin and β2TF). This multi-functional design achieves rapid comprehensive detection in a single device, making the increased complexity worthwhile by providing versatile diagnostic capability in one integrated system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides rapid, sensitive, and specific detection of CSF leakage within 30 minutes, allowing immediate surgical intervention and reducing the risk of complications.
Implementation Method 1
the conjugate pad thereof, downstream in lateral flow from the sample pad, comprises both (A) and (B) thereon, wherein: (A) is a first plurality of transferrin-binding antibodies conjugated to a first plurality of nanoparticles
Implementation Method 2
a plurality of lectin molecules conjugated to a second plurality of nanoparticles
Implementation Method 3
A combination of protein separation and detection, using electrophoresis and mass spectrometry, has been successfully applied to identify protein biomarkers in CSF
Implementation Method 4
distributing the liquid biological sample on to a sample pad of a lateral flow device which comprises, in lateral flow sequence: a sample pad, a conjugate pad, a binding portion, and an absorbent pad, so as to permit the sample to flow along the lateral flow device
Data Source
AI summary
The invention encompasses methods and test strips for detecting the presence of cerebrospinal fluid (CSF) in a biological sample with a lateral flow device which uses lectin conjugates, anti-antigen conjugates, an immobilized serum line, and an immobilized anti-antigen line.